NMT2 Antibody (N-term) Blocking Peptide

Background:
N-myristoyltransferase (NMT) catalyzes the reaction of N-terminal myristoylation of many signaling proteins. It transfers myristic acid from myristoyl coenzyme A to the amino group of a protein's N-terminal glycine residue. Biochemical evidence indicates the presence of several distinct NMTs, varying in apparent molecular weight and /or subcellular distribution. The predicted 498-amino acid of human NMT2 protein shares 77% and 96% sequence identity with human NMT1 and mouse Nmt2 comprise two distinct families of N-myristoyltransferases.

Other Names:
Glycylpeptide N-tetradecanoyltransferase 2, Myristoyl-CoA:protein N-myristoyltransferase 2, NMT 2, Peptide N-myristoyltransferase 2, Type II N-myristoyltransferase, NMT2

Target/Specificity:
The synthetic peptide sequence is selected from aa 31~46 of human NMT2.

Gene Name: NMT2 {ECO:0000303|PubMed:9506952, ECO:0000312|HGNC:HGNC:7858}

Gene ID: 9397
Primary Accession: O60551
Other Accession: NMT2_HUMAN
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.